Clarity Pharmaceuticals' SECuRE trial shows promising results
Clarity Pharmaceuticals (ASX:CU6) has announced that the SECuRE trial, a Phase 1/2a study of 67Cu-SAR-bisPSMA for metastatic castration-resistant prostate cancer.
Clarity Pharmaceuticals (ASX:CU6) has announced that the SECuRE trial, a Phase 1/2a study of 67Cu-SAR-bisPSMA for metastatic castration-resistant prostate cancer.
Impact Minerals (ASX:IPT) has reported significant progress at its Commonwealth Gold–Silver Project in New South Wales.
Mithril Silver and Gold (ASX:MTH) has commenced its maiden drill program at Target 3 within its multi-target Copalquin gold-silver district.
GBM Resources (ASX:GBM) has entered into an agreement with a subsidiary of Evolution Mining (ASX:EVN) to sell its Cloncurry Project in Queensland.
Beverage company The Calmer Co International (ASX:CCO) has reported its strongest single-month performance since listing on the ASX in 2018.
Boab Metals (ASX:BML) has outlined its strategic priorities for 2026 as construction ramps up at its fully funded Sorby Hills Silver-Lead Project.
Woodside Energy (ASX:WDS) will supply three LNG cargoes annually to major Japanese importer JERA over five years, starting in 2027, under a deal
GreenTech Metals (ASX:GRE) announced the recommencement of its Phase 1 drilling program at the Munni Munni Platinum-Palladium-Copper-Nickel Project in Western Australia, following the festive season break.
Viking Mines (ASX:VKA) has expanded its landholding in Nevada, USA, increasing its total footprint to approximately 20km2.
Wia Gold (ASX:WIA) has appointed experienced mining executive Henk Diederichs as its new Managing Director and CEO, effective Feb. 1.
TechGen Metals (ASX:TG1) announced an exploration program for 2026 across its four core Australian projects.
Atomo Diagnostics (ASX:AT1) has secured a purchase order worth $502,000 for its HIV self-tests, which will be supplied to an African country in March.